Skip to content

LAFAUT FARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LAFAUT FARMA

BE 0870.074.657
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€248,016
2024 · €235,560+€12,456
Equity
€1.2m
2024 · €940,818+€248,015
Cash
€246,387
2024 · €274,743-€28,356
Balance sheet total
€1.4m
2024 · €1.2m+€161,370

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€154,173

    up €154,173 (+3,911%), from €3,942 to €158,115

    of which Trade receivables: +€148,543

  • Current investments +€147,356

    up €147,356 (+22.6%), from €652,644 to €800,000

  • Deferred charges and accrued income -€130,642

    down €130,642 (-95.2%), from €137,300 to €6,658

  • Cash -€28,356

    down €28,356 (-10.3%), from €274,743 to €246,387

    mainly Receivables within one year (-€154,173) and Current investments (-€147,356)

  • Stocks and contracts +€16,039

    up €16,039 (+12.9%), from €124,563 to €140,602

Equity and liabilities
  • Reserves +€825,024

    up €825,024 (+239%), from €345,209 to €1.2m

  • Profit (loss) carried forward -€577,009

    down €577,009 (-100%), from €577,009 to €0

  • Other debts -€100,296

    down €100,296 (-49.6%), from €202,161 to €101,865

Income statement
  • Gross operating margin +€44,143

    up €44,143 (+14.0%), from €315,845 to €359,988

  • Staff costs +€37,854

    up €37,854 (+408%), from €9,281 to €47,135

  • Financial income +€7,774

    up €7,774 (+36.5%), from €21,311 to €29,085

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €235,560
Gross operating margin +€44,143
Staff costs -€37,854
Depreciation +€3,361
Other operating charges -€1,202
Financial income +€7,774
Financial charges -€974
Taxes -€2,791
Result 2025 €248,016
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€125,686
Investment -€154,042
Financing -€1
Cash 2024 €274,743
Net result for the year +€248,016
Depreciation +€3,886
Stocks and contracts -€16,039
Receivables within one year -€154,173
Deferred charges and accrued income +€130,642
Trade debts +€6,459
Tax, wage and social debts +€6,103
Other debts -€100,296
Accrued charges and deferred income +€1,088
Investment in fixed assets (net) -€6,686
Current investments -€147,356
Contributions, distributions and other -€1
Cash 2025 €246,387
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,213,722 €1,375,092 +€161,370 +13.3%
Fixed assets 21/28 €20,530 €23,330 +€2,800 +13.6%
Tangible fixed assets 22/27 €20,511 €23,311 +€2,800 +13.7%
Land and buildings 22 €18,357 €18,996 +€639 +3.5%
Furniture and vehicles 24 €2,154 €4,315 +€2,161 +100%
Financial fixed assets 28 €19 €19 -€0 -2.2%
Current assets 29/58 €1,193,192 €1,351,762 +€158,570 +13.3%
Stocks and contracts in progress 3 €124,563 €140,602 +€16,039 +12.9%
Stocks 30/36 €124,563 €140,602 +€16,039 +12.9%
Amounts receivable within one year 40/41 €3,942 €158,115 +€154,173 +3,911%
Trade receivables 40 €3,332 €151,875 +€148,543 +4,458%
Other amounts receivable 41 €610 €6,240 +€5,630 +923%
Current investments 50/53 €652,644 €800,000 +€147,356 +22.6%
Cash at bank and in hand 54/58 €274,743 €246,387 -€28,356 -10.3%
Deferred charges and accrued income 490/1 €137,300 €6,658 -€130,642 -95.2%
Total equity and liabilities 10/49 €1,213,722 €1,375,092 +€161,370 +13.3%
Equity 10/15 €940,818 €1,188,833 +€248,015 +26.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €345,209 €1,170,233 +€825,024 +239%
Distributable reserves 133 €345,209 €1,170,233 +€825,024 +239%
Profit (loss) carried forward 14 €577,009 €0 -€577,009 -100%
Amounts payable 17/49 €272,904 €186,258 -€86,646 -31.7%
Amounts payable within one year 42/48 €272,904 €185,170 -€87,734 -32.1%
Trade debts 44 €59,102 €65,561 +€6,459 +10.9%
Suppliers 440/4 €59,102 €65,561 +€6,459 +10.9%
Taxes, remuneration and social security 45 €11,641 €17,744 +€6,103 +52.4%
Taxes 450/3 €5,482 €5,635 +€153 +2.8%
Remuneration and social security 454/9 €6,159 €12,109 +€5,950 +96.6%
Other amounts payable 47/48 €202,161 €101,865 -€100,296 -49.6%
Accrued charges and deferred income 492/3 - €1,088 +€1,088
Remuneration, social security and pensions 62 €9,281 €47,135 +€37,854 +408%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,247 €3,886 -€3,361 -46.4%
Other operating charges 640/8 - €1,202 +€1,202
Gross operating margin 9900 €315,845 €359,988 +€44,143 +14.0%
Operating profit (loss) 9901 €299,317 €307,765 +€8,448 +2.8%
Financial income 75/76B €21,311 €29,085 +€7,774 +36.5%
Recurring financial income 75 €21,311 €29,085 +€7,774 +36.5%
Financial charges 65/66B €10,955 €11,929 +€974 +8.9%
Recurring financial charges 65 €10,955 €11,929 +€974 +8.9%
Profit (loss) for the period before taxes 9903 €309,673 €324,921 +€15,248 +4.9%
Income taxes 67/77 €74,113 €76,904 +€2,791 +3.8%
Profit (loss) for the period 9904 €235,560 €248,016 +€12,456 +5.3%
Profit (loss) for the period to be appropriated 9905 €235,560 €248,016 +€12,456 +5.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.